AMT’s gene therapy successful in treating Duchenne muscular dystrophy Amsterdam Molecular Therapeutics , a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy within an animal model using its proprietary gene therapy. The proof of concept studies were performed in collaboration with the band of Professor Irene Bozzoni and demonstrated performance in the heart as well as in skeletal muscle tissue. In a previous study, AMT’s gene therapy approach was shown to be effective in the treating diseased human muscle cells attained from biopsies of DMD individuals http://edpillsotc.com .
Crisis nurses are also frightened about how Ebola individuals would affect their departments. With an average wait time of 4 nearly.5 hours, the typical U.S. Emergency room would be nearly crushed by an influx of Ebola individuals immediately, and those who believe that they could have Ebola. Half of essential care, emergency personnel say they wouldn’t obtain anywhere near Ebola individuals Many hospital staff members, which are already an issue in some areas, also expressed reluctance toward treating Ebola patients. About 50 percent of those who currently work in crisis care say they wouldn’t get anywhere near Ebola patients, which throughout a main outbreak would create an higher shortage of recruiting actually. Among those polled, only one 1 % of medical personnel at acute care hospitals say they have the capability to treat more than 10 Ebola patients at one time.